Stay updated on Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial page.

Latest updates to the Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial page
- CheckyesterdayChange DetectedA government funding notice was added to the page, noting potential delays and directing readers to cc.nih.gov and opm.gov. The site revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check8 days agoChange DetectedAdded a glossary display and new metadata items: 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with 'Revision: v3.4.0' in the footer. Removed the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check16 days agoChange DetectedSponsor and collaborator information, as well as access to study documents and related metadata, have been removed from the page.SummaryDifference19%

- Check23 days agoChange Detected- Revision: v3.3.4 is now displayed, replacing Revision: v3.3.3. This is a page version update.SummaryDifference0.0%

- Check44 days agoChange DetectedA consolidated Locations section is added listing New South Wales, Victoria, and Western Australia, and the separate NSW, Victoria, and WA location subsections are removed (revision update to v3.3.3).SummaryDifference0.4%

- Check66 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2; a minor maintenance update with no impact on study content or functionality, To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial page.